We would like to ask you about your experience regarding your treatment with IV Bebtelovimab (monoclonal antibodies.) Please only answer this survey if you have received this particular type of monoclonal antibodies, which is the most recent one approved for treatment in patients with COVID19.  All answers will be kept strictly confidential.  Thank you for helping us understand how effective this treatment is for patients with COVID-19.

1.What is your age?

Under 12

12 to 17

18 to 24

25 to 34

35 to 44

45 to 54

55 to 64

65 to 74

75 or older

2.What is your gender?

Female

Male

3.Which is your race?

White or Caucasian

Black or African American

Hispanic or Latino

Asian or Asian American

American Indian or Alaska Native

Another race

4.Have you had COVID before (check all that apply)?

Yes - in 2020

Yes - in 2021

Yes - in 2022 (prior to current infection)

No - this is my first time having COVID

5.What is your vaccination status?

One COVID shot

Two COVID shots

Three COVID shots

Four COVID shots

No COVID shots

6.When was your last COVID shot?

Within the past 2 weeks

2 - 4 weeks ago

1 - 3 months ago

3 - 6 months ago

6 - 12 months ago

12 months or longer

7.How long ago did you receive IV Bebtelovimab?

Less than 1 week

1 - 2 weeks

3 - 4 weeks

More than a month

8.Where did you receive treatment?

BreatheMD

Other (please specify)

9.On the day of your treatment, how severe were your symptoms?

No symptoms

Mild symptoms - I felt like I had a cold.

Moderate symptoms - I felt horrible but was able to eat and drink.

Severe symptoms - I was on the verge of going to the ER (unable to break fever, unable to eat or drink, shortness of breath, extreme lethargy)

10.Which of the following best describes your response?

Felt improvement in less than 48 hours and continued to improve

Felt improvement after 48 hours and continued to improve

Felt improvement initially but then worsened and went to ER

Symptoms worsened but eventually got better

Symptoms worsened and I went to the ER

No change in symptoms but eventually got better

Never had symptoms but tested positive for COVID-19

Other (please specify)

11.Please indicate which of the following apply to you:

Age 65 or older

High blood pressure or heart disease

Lung disease (asthma, COPD, bronchiectasis, other)

Obesity

Diabetes

Smoker

Immunocompromised

Pregnant

Cancer

Other (please specify)

None of the above

12.Please indicate which of these treatments you took in addition to monoclonal antibodies.

Ivermectin

Hydroxychloroquine

Azithromycin

Vitamin D

Zinc

Vitamin C

Quercetin

Steroid inhaler or nebulizer treatment

Melatonin

Aspirin

Pepcid

Other (please specify)

13.If you took ivermectin and/or hydroxychloroquine, when did you start taking these additional medications?

Before IV monoclonal antibodies

The same day as IV monoclonal antibodies

The day after IV monoclonal antibodies

More than 24 hours after IV monoclonal antibodies

14.If you took Ivermectin and/or hydroxychloroquine, which of the following applies?

I noticed more improvement from the IV Bebtelovimab.

I noticed more improvement from the hydroxychloroquine and/or ivermectin.

I noticed no significant improvement from either treatment.

I took them on the same day so difficult to say.

Other (please specify)

15.Please indicate any side effects that you experienced after your IV monoclonal antibodies.

Pain, swelling, bruising at the injection site lasting longer than 24 hours

Covid symptoms worsened and did not improve

None

Other (please specify)

16.Would you recommend IV Bebtelovimab to a loved one with COVID-19?

Yes

No